Back to MS MSD Partners, L.P.
OCUL
2 quarters
Position history for MSMSD Partners, L.P.'s holdings in Ocular Therapeutix, Inc.
No. MSD Partners exited its OCUL (Ocular Therapeutix) position in Q3 2022. Its Q2 2022 13F listed 1,016,302 shares worth $4.1M. MSD Partners first reported OCUL in Q2 2022 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$4.1M
Total Shares Change
-1M
Quarter-by-Quarter History
Other major holders of OCUL: FMR LLC, BlackRock, Inc.